3-41821153-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_017886.4(ULK4):c.1765-1647T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 152,012 control chromosomes in the GnomAD database, including 6,119 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.25   (  6119   hom.,  cov: 32) 
Consequence
 ULK4
NM_017886.4 intron
NM_017886.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.29  
Publications
12 publications found 
Genes affected
 ULK4  (HGNC:15784):  (unc-51 like kinase 4) This gene encodes a member of the unc-51-like serine/threonine kinase (STK) family. Members of this protein family play a role in neuronal growth and endocytosis. The encoded protein is likely involved in neurite branching, neurite elongation and neuronal migration. Genome-wide association studies (GWAS) indicate an association of variations in this gene with blood pressure and hypertension. Sequence variations in this gene may also be be associated with psychiatric disorders, including schizophrenia and bipolar disorder. Pseudogenes associated with this gene have been identified and are located on chromosome 15. [provided by RefSeq, Jul 2016] 
ULK4 Gene-Disease associations (from GenCC):
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.443  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.255  AC: 38695AN: 151894Hom.:  6097  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
38695
AN: 
151894
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.255  AC: 38748AN: 152012Hom.:  6119  Cov.: 32 AF XY:  0.255  AC XY: 18974AN XY: 74298 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
38748
AN: 
152012
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
18974
AN XY: 
74298
show subpopulations 
African (AFR) 
 AF: 
AC: 
18599
AN: 
41440
American (AMR) 
 AF: 
AC: 
2937
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
664
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
850
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
899
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
2383
AN: 
10574
Middle Eastern (MID) 
 AF: 
AC: 
109
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
11578
AN: 
67948
Other (OTH) 
 AF: 
AC: 
532
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 1379 
 2757 
 4136 
 5514 
 6893 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 382 
 764 
 1146 
 1528 
 1910 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
641
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.